Jump to:
loading...| Preferred Name | liposomal doxorubicin | |
| Synonyms |
pegylated liposomal doxorubicin Lipodox Caelyx Doxil DOX-SL |
|
| ID |
http://purl.bioontology.org/ontology/MESH/C506643 |
|
| altLabel |
pegylated liposomal doxorubicin Lipodox Caelyx Doxil DOX-SL |
|
| cui |
C0701182 C1522683 C0701183 C0717726 C0279284 |
|
| Has mapping qualifier | ||
| HM |
D011092 D004317/Q000031 |
|
| Inverse of RB |
0 |
|
| isa | ||
| LT |
TRD |
|
| Mapped to | ||
| MDA |
20060103 |
|
| MeSH Frequency |
1226 |
|
| MMR |
20141027 |
|
| notation |
C506643 |
|
| PA |
D000903 |
|
| prefLabel |
liposomal doxorubicin |
|
| SC |
1 |
|
| Scope Statement |
single use of pegylated liposomal doxorubicin has been reported to be safe and effective with varying treatment in patients with advanced hepatocellular carcinoma |
|
| SRC |
Am J Clin Oncol. 2005 Dec;28(6):540-6 |
|
| TERMUI |
T486048 T013193 T013194 T663661 T836987 T838638 |
|
| TH |
US MX UK CA ES NLM (2006) DE AU NLM (1998) NLM (2014) FR |
|
| tui |
T109 T195 T121 |
Create mapping